JP2015536947A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015536947A5 JP2015536947A5 JP2015540764A JP2015540764A JP2015536947A5 JP 2015536947 A5 JP2015536947 A5 JP 2015536947A5 JP 2015540764 A JP2015540764 A JP 2015540764A JP 2015540764 A JP2015540764 A JP 2015540764A JP 2015536947 A5 JP2015536947 A5 JP 2015536947A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- acceptable salt
- pharmaceutically acceptable
- compound according
- ring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261722151P | 2012-11-03 | 2012-11-03 | |
| US61/722,151 | 2012-11-03 | ||
| PCT/US2013/067673 WO2014070978A1 (en) | 2012-11-03 | 2013-10-31 | Inhibitors of cytomegalovirus |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015536947A JP2015536947A (ja) | 2015-12-24 |
| JP2015536947A5 true JP2015536947A5 (enExample) | 2016-12-15 |
| JP6482466B2 JP6482466B2 (ja) | 2019-03-13 |
Family
ID=49620280
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015540764A Active JP6482466B2 (ja) | 2012-11-03 | 2013-10-31 | サイトメガロウイルスの阻害剤 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US9284310B2 (enExample) |
| EP (1) | EP2914591B1 (enExample) |
| JP (1) | JP6482466B2 (enExample) |
| WO (1) | WO2014070978A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10118904B2 (en) | 2015-06-05 | 2018-11-06 | Vertex Pharmaceuticals Incorporated | Triazoles for the treatment of Demyelinating Diseases |
| ES2953467T3 (es) | 2016-04-15 | 2023-11-13 | Elanco Animal Health Gmbh | Derivados de pirazolopirimidina |
| CN111448194A (zh) * | 2017-12-04 | 2020-07-24 | 拜耳作物科学股份公司 | 3-氨基-[1，2，4]-三唑衍生物及其用于防治不希望的植物生长的用途 |
| CN108003062B (zh) * | 2017-12-25 | 2020-08-11 | 常州吉恩药业有限公司 | 一种单boc保护双氨基化合物的合成方法 |
| US11072610B2 (en) | 2018-09-12 | 2021-07-27 | Novartis Ag | Antiviral pyridopyrazinedione compounds |
| AR118243A1 (es) | 2019-03-07 | 2021-09-22 | Pi Industries Ltd | Compuestos heterocíclicos fusionados y su uso como agentes de control de plagas |
| AR119140A1 (es) | 2019-06-13 | 2021-11-24 | Pi Industries Ltd | Compuestos heterocíclicos fusionados y su uso como agentes de control de plagas |
| MX2022000232A (es) * | 2019-06-25 | 2022-04-25 | Microbiotix Inc | Composiciones y metodos para tratar o evitar infecciones oculares con filociclovir. |
| WO2021033141A1 (en) | 2019-08-20 | 2021-02-25 | Pi Industries Ltd. | Fused heterocyclic compounds and their use as pest control agents |
| CN114667285B (zh) | 2019-09-26 | 2025-08-08 | 诺华股份有限公司 | 抗病毒吡唑并吡啶酮化合物 |
| AR121344A1 (es) | 2020-02-18 | 2022-05-11 | Pi Industries Ltd | Compuestos heterocíclicos fusionados y su uso como agentes para el control de plagas |
| TW202334117A (zh) | 2020-08-24 | 2023-09-01 | 美商達薩瑪治療公司 | Ｓａｒｍ１之抑制劑 |
| TW202304919A (zh) | 2021-03-31 | 2023-02-01 | 印度商皮埃企業有限公司 | 稠合雜環化合物及其作為害蟲控制劑之用途 |
| JP2025513455A (ja) | 2022-04-22 | 2025-04-24 | バーテックス ファーマシューティカルズ インコーポレイテッド | 疼痛の治療のためのヘテロアリール化合物 |
| WO2025177310A1 (en) | 2024-02-23 | 2025-08-28 | Pi Industries Ltd. | Fused heterocyclic compounds and its uses thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1137632B1 (en) * | 1998-12-09 | 2004-07-28 | Wyeth | Thiourea inhibitors of herpes viruses |
| US6166028A (en) | 1998-12-09 | 2000-12-26 | American Home Products Corporation | Diaminopuridine-containing thiourea inhibitors of herpes viruses |
| CN1367785A (zh) | 1998-12-09 | 2002-09-04 | 美国家庭用品有限公司 | 含取代的苯二胺基团的含杂环羧酰胺的疱疹病毒硫脲抑制剂 |
| ID30158A (id) | 1998-12-09 | 2001-11-08 | American Home Prod | Thiourea yang mengandung heterosiklik karboksamida, pencegah-pencegah virus-virus herpes yang mengandung gugus fenilenadiamina |
| BR0209054A (pt) * | 2001-04-19 | 2004-04-20 | Bayer Ag | Arilsulfonamidas como agentes antivirais |
| EP1562911B1 (en) | 2002-11-01 | 2010-01-06 | Vertex Pharmaceuticals Incorporated | Compositions useful as inhibitors of jak and other protein kinases |
| SE0203654D0 (sv) * | 2002-12-09 | 2002-12-09 | Astrazeneca Ab | New compounds |
| US20040248850A1 (en) | 2003-02-11 | 2004-12-09 | Kemia, Inc. | Compounds for the treatment of HIV infection |
| US20090196912A1 (en) | 2004-07-30 | 2009-08-06 | Gpc Botech Ag | Pyridinylamines |
| EP1896461A2 (en) | 2005-06-30 | 2008-03-12 | Amgen Inc. | Bis-aryl kinase inhibitors and their use in the treatment of inflammation, angiogenesis and cancer |
| WO2009011850A2 (en) | 2007-07-16 | 2009-01-22 | Abbott Laboratories | Novel therapeutic compounds |
| US20110294853A1 (en) | 2008-09-12 | 2011-12-01 | Benjamin Pelcman | Bis Aromatic Compounds for Use in the Treatment of Inflammation |
| EP2177521A1 (en) | 2008-10-14 | 2010-04-21 | Almirall, S.A. | New 2-Amidothiadiazole Derivatives |
| WO2010077582A1 (en) | 2008-12-16 | 2010-07-08 | Merck Sharp & Dohme Corp. | Triazole derivatives for treatment of alzheimer's disease |
| WO2012004217A1 (en) | 2010-07-06 | 2012-01-12 | Novartis Ag | Cyclic ether compounds useful as kinase inhibitors |
-
2013
- 2013-10-31 US US14/440,086 patent/US9284310B2/en active Active
- 2013-10-31 JP JP2015540764A patent/JP6482466B2/ja active Active
- 2013-10-31 WO PCT/US2013/067673 patent/WO2014070978A1/en not_active Ceased
- 2013-10-31 EP EP13792794.3A patent/EP2914591B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016503403A5 (enExample) | ||
| JP2018533593A5 (enExample) | ||
| JP2014520767A5 (enExample) | ||
| JP2013544860A5 (enExample) | ||
| JP2016505614A5 (enExample) | ||
| JP2019501125A5 (enExample) | ||
| JP2015500843A5 (enExample) | ||
| JP2016516043A5 (enExample) | ||
| RU2013108348A (ru) | Конденсированные гетероарилы и их применение | |
| JP2012092103A5 (enExample) | ||
| JP2013523614A5 (enExample) | ||
| JP2014508811A5 (enExample) | ||
| JP2017501237A5 (enExample) | ||
| JP2015504081A5 (enExample) | ||
| JP2016503052A5 (enExample) | ||
| JP2012506389A5 (enExample) | ||
| JP2013537203A5 (enExample) | ||
| JP2014513051A5 (enExample) | ||
| JP2015522650A5 (enExample) | ||
| JP2014526533A5 (enExample) | ||
| JP2017517565A5 (enExample) | ||
| JP2015500842A5 (enExample) | ||
| JP2014500296A5 (enExample) | ||
| JP2017537937A5 (enExample) | ||
| RU2016151420A (ru) | Новое терапевтическое применение производных бензилиденгуанидина для лечения протеинопатий |